Hypercholesterolaemia and coronary risk

dc.contributor.authorKer, James A.
dc.date.accessioned2016-06-14T07:55:53Z
dc.date.available2016-06-14T07:55:53Z
dc.date.issued2016-05
dc.description.abstractStudies have shown that only 10.6% of people with hypercholesterolaemia receive a statin or treatment. There is a within-person variability of cholesterol measurements and therefore a one-time measurement of cholesterol tends to underestimate the strength of the relationship between cholesterol and coronary heart disease. Multiple cholesterol measurements over time (decades) such as done in some epidemiological studies are therefore important to get an idea of life-time risk of atherosclerosis as the disease develops over decades.en_ZA
dc.description.departmentInternal Medicineen_ZA
dc.description.librarianam2016en_ZA
dc.description.urihttp://www.specialistforum.co.zaen_ZA
dc.identifier.citationKer, J 2016, 'The Hypercholesterolaemia and coronary risk', The Specialist Forum, vol. 16, no. 4, pp. 11.en_ZA
dc.identifier.issn2218-8282
dc.identifier.urihttp://hdl.handle.net/2263/53109
dc.language.isoenen_ZA
dc.publisherNew Media Publishingen_ZA
dc.rights© The Specialist Forumen_ZA
dc.subjectHypercholesterolaemiaen_ZA
dc.subjectCardiovascularen_ZA
dc.subjectTreatmenten_ZA
dc.subjectSouth Africa (SA)en_ZA
dc.titleHypercholesterolaemia and coronary risken_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ker_Hypercholesterolaemia_2016.pdf
Size:
562.15 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: